Increlex Trademark Details

Increlex was registered on Tuesday, November 27, 2007 and is currently owned by Ipsen Biopharmaceuticals, Inc under the registration number 3345436 . This mark is alive with a status of Section 8 & 15-Accepted and Acknowledged. The last case file activity for this mark occured 10 years ago on Friday, June 14, 2013, according to the United State Patent & Trademark Office
Word Mark Increlex
Status Alive Registered 702 — Section 8 & 15-Accepted and Acknowledged

Current Owner

Ipsen Biopharmaceuticals, Inc of Brisbane, CA

View all trademarks for Ipsen Biopharmaceuticals, Inc
Other Trademarks for Ipsen Biopharmaceuticals, Inc

Previous Owners

Tercica, Inc. of Brisbane, CA

View all trademarks for Tercica, Inc.
Other Trademarks for Tercica, Inc.
Serial Number 78696484
Registration Number 3345436
Status Date Friday, June 14, 2013
Filing Date Friday, June 14, 2013
Registration Date Tuesday, November 27, 2007
Attorney Anne H. Peck

Correspondent

Anne H. Peck
COOLEY LLP
1299 Pennsylvania Ave., NW, Suite 700
Washington DC 20004-2400

Case File Statements

Indication of Colors Color is not claimed as a feature of the mark.
Goods & Services Pharmaceutical preparations for the treatment of endocrine disorders

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 6 — Active
Status Date Monday, August 29, 2005
First Use Anywhere Wednesday, January 4, 2006
First Use In Commerce Wednesday, January 4, 2006
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.